The Supreme Court on Monday temporarily reinstated a Food and Drug Administration (FDA) rule that allows the abortion pill mifepristone to be prescribed via telemedicine and dispensed through the mail. The order pauses a lower-court ruling that had required patients to visit a health care provider in person to obtain the medication.
The lower court had reinstated an FDA requirement for in-person visits, effectively blocking mail-order access to mifepristone. The Supreme Court’s intervention temporarily restores the FDA’s more permissive rule while litigation continues.
The Federalist’s headline described the drugs as “harmful abortion drugs.” The Blaze reported that a conservative justice on the Supreme Court restored access to the abortion drug. Mother Jones and The New York Times noted the restoration of telemedicine and mail access. Axios reported the temporary restoration of mail-order prescribing.
The legal challenge to the FDA’s rule is ongoing, and the Supreme Court’s order is temporary.
We don't rate truth. We strip the spin and show you which perspectives covered the story. You decide.
Read the original coverage
💬 Comments
📜 Comment Policy